Quick Answer: Psychiatry practice EBITDA multiples are the figure buyers apply to a practice’s adjusted EBITDA to set its value. In our transaction experience, multiples scale with size and quality: small owner-operated practices often transact at low single-digit multiples (and are frequently valued on seller’s discretionary earnings instead), mid-size groups in the mid single digits, and scaled, well-run behavioral health platforms were widely discussed in the 8–12× EBITDA range in 2025. Bigger, cleaner, less owner-dependent practices earn higher multiples. (Illustrative — not transaction guidance.)
If you have started researching a sale, you have met the term psychiatry practice EBITDA multiples — and probably a confusing spread of numbers. This guide gives you illustrative benchmark ranges for 2026 and, more importantly, explains why one practice earns a higher multiple than another, so you can place your own practice on the spectrum.
What is an EBITDA multiple?
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization — a clean proxy for a practice’s core operating profit. An EBITDA multiple is simply how many times that profit a buyer will pay.
Practice value ≈ Adjusted EBITDA × EBITDA multiple
So a practice with $1,000,000 of adjusted EBITDA valued at a 6× multiple is worth roughly $6,000,000. (Illustrative figures.) Two variables drive everything: getting adjusted EBITDA right, and justifying the multiple. Adjusted (or “normalized”) EBITDA strips out one-time costs, the owner’s above-market pay, and personal expenses so the buyer sees true, repeatable profit.
A related term you will see: psychiatry practice EBITDA margin — EBITDA as a percentage of revenue. Healthy margins, especially in cash-pay models, support both a higher multiple and a higher absolute value.
What multiple do psychiatry practices sell for? (Illustrative 2026 benchmarks)
Multiples are not one number — they are a spectrum tied to size, model, and risk. The ranges below are illustrative and drawn from how the market generally prices behavioral health assets.
| Practice profile | Typically valued on | Illustrative multiple range (2026) | Why it sits here |
| Solo / single-provider | SDE (not EBITDA) | Low — small SDE multiple | High key-person risk; owner is the practice |
| Small group (2–5 providers) | EBITDA | Low-to-mid single digits | Some provider depth; cleaner financials help |
| Multi-site group | EBITDA | Mid single digits | Management layer reduces risk |
| Scaled platform / MSO-backed | EBITDA | High single digits to low double digits (≈8–12×) | Scale, systems, and growth de-risk the deal |
| Cash-pay / concierge / subspecialty | EBITDA | Premium vs. insurance-reliant peers | Pricing power, cleaner collections, demand |
Illustrative — not transaction guidance. Scaled behavioral health platforms were widely discussed in the 8–12× EBITDA area in 2025; individual practices, especially smaller ones, generally trade well below platform multiples. Your actual multiple depends on the drivers below.
The central pattern: the same dollar of profit is worth more inside a larger, more systematized practice than inside a solo one. This is the “size premium,” and it is the engine behind private-equity roll-up strategies.
Why do psychiatry practice multiples vary so much?
A buyer’s multiple is really a risk score. The lower the risk that profit disappears after the sale, the higher the multiple. These factors move it:
- Scale. Larger EBITDA earns a higher multiple because scale brings management depth and resilience.
- Owner dependence. If revenue, referrals, and patients follow the owner out, the multiple drops. Provider depth lifts it.
- Provider concentration. Earnings spread across several retained clinicians are safer than earnings concentrated in one or two.
- Payer mix. Cash-pay and strong commercial insurance support higher multiples than heavy reliance on the lowest-reimbursing plans.
- Growth. Documented, durable growth earns a forward-looking premium.
- Earnings quality. Clean, well-documented profit that survives a quality-of-earnings review protects the multiple; messy books invite discounts.
- Model. Scalable telepsychiatry and premium subspecialties (child and adolescent, addiction, interventional clinics) can command premiums when their economics are clean.
EBITDA multiple vs. revenue multiple
You may also see practices quoted as a multiple of revenue. Treat revenue multiples as rough shorthand only. Revenue ignores profitability — two practices with identical revenue and very different margins are worth very different amounts. Serious buyers underwrite on EBITDA (or SDE), not revenue. If someone values your practice purely on revenue, ask what margin assumption sits underneath it.
How to estimate your own multiple
- Calculate adjusted EBITDA. Start with profit; add back owner above-market pay, personal expenses, and one-time costs.
- Place yourself on the size spectrum. Solo, small group, multi-site, or platform-scale.
- Score your risk drivers. Honest read on owner dependence, payer mix, provider concentration, and growth.
- Select a range, not a point. Anchor low if owner-dependent; move up for scale, clean books, and growth.
- Cross-check against real psychiatry comps, not generic medical-practice data.
For the full valuation method behind this, see psychiatry practice valuation. For what buyers scrutinize when they test your earnings, see what buyers look for.
Key Takeaways
- EBITDA multiple = how many times adjusted profit a buyer pays; value ≈ adjusted EBITDA × multiple.
- Multiples scale with size and quality: solo practices low (often valued on SDE instead), platforms highest (≈8–12× EBITDA in 2025, illustrative).
- The multiple is a risk score — lower risk that profit disappears after the sale means a higher multiple.
- Owner dependence, payer mix, provider concentration, growth, and earnings quality move your multiple most.
- Underwrite on EBITDA, not revenue; revenue multiples are rough shorthand only.
Frequently Asked Questions
What multiple does a psychiatry practice sell for?
It varies widely by size and model. Solo practices often transact at low single-digit multiples and are frequently valued on seller’s discretionary earnings instead, while mid-size groups land in the mid single digits and scaled behavioral health platforms were discussed in the 8–12× EBITDA range in 2025. These are illustrative ranges, not guarantees.
What is the average psychiatry practice EBITDA multiple?
There is no single meaningful average because multiples scale with size, model, and risk. A solo practice and a multi-site platform sit at opposite ends. A range built from your own adjusted EBITDA and risk drivers is far more useful than an industry average.
How do I calculate my psychiatry practice’s adjusted EBITDA?
Start with operating profit, then add back the owner’s above-market compensation, personal or discretionary expenses run through the practice, and one-time, non-recurring costs. The result is the repeatable profit a buyer will actually pay a multiple on.
Is a psychiatry practice valued on EBITDA or revenue?
Serious buyers underwrite on EBITDA (or SDE for solo practices), not revenue. Revenue multiples are sometimes quoted as shorthand but ignore profitability, so two practices with the same revenue and different margins can be worth very different amounts.
What is a good EBITDA margin for a psychiatry practice?
Margins vary by model, with cash-pay and concierge practices generally running higher than insurance-dependent ones. A healthy, well-documented margin supports both a higher multiple and a higher absolute value, because it signals durable, efficient profit.
Why do larger psychiatry practices get higher multiples?
Scale brings management depth, provider redundancy, and systems that make profit more resilient to any one person leaving. Lower risk that earnings disappear after the sale translates directly into a higher multiple — the size premium that drives consolidation.
Conclusion
Psychiatry practice EBITDA multiples are less a fixed price list than a risk scorecard. Get your adjusted EBITDA right, place your practice honestly on the size-and-quality spectrum, and you will hold a defensible multiple range before any buyer quotes one. The owners who capture the top of their range are the ones who reduced risk — owner dependence, payer concentration, messy books — long before they went to market.
To benchmark your practice against real psychiatry transaction multiples confidentially, the advisory team at Olympic M&A works exclusively in psychiatry and behavioral health deals.
